1. Academic Validation
  2. The role of miR-141/ Sirt1 in colon cancer

The role of miR-141/ Sirt1 in colon cancer

  • J BUON. 2020 Nov-Dec;25(6):2665-2671.
Yongliang Li 1 Feiteng Gu Xi Lin
Affiliations

Affiliation

  • 1 Second Department of Gastrointestinal Surgery, The Affiliated Hospital of Putian University, Putian, China.
PMID: 33455111
Abstract

Purpose: To explore the effects of micro ribonucleic acid-141 (miR)-141 on the proliferation and Apoptosis of colon Cancer cells and its association with the Sirtuin 1 (SIRT1) expression.

Methods: The samples of stage I, II, III and IV colon Cancer were obtained, and the miRNA expression levels was analyzed, with normal colon tissues as controls. The expression of miR-141 and miR-34 was detected via quantitative reverse transcription-polymerase chain reaction (qRT-PCR), and the cell proliferation and Apoptosis in each group were detected via cell counting kit-8 (CCK8) assay, respectively. Finally, the protein expressions of SIRT1, Caspase-3 and Caspase-8 were determined using Western blotting.

Results: The expressions of miR-141 and miR-34 (miR-34 is mentioned in previous methods. Furthermore, we found the expression of miR-141 increasing with the progression of colon Cancer, which was higher in stage III than in stage I-II and also higher in stage IV than in stage III. miR-34 was also highly expressed in stage IV colon Cancer in our study were up-regulated in the progression of colon Cancer. Overexpression of miR-141 could promote cell proliferation (p<0.05) and inhibit Apoptosis (p<0.05), while inhibition on miR-141 expression could significantly weaken cell proliferation (p<0.05) and promote Apoptosis (p<0.05). The results of luciferase reporter assay showed that miR-141 obviously inhibited SIRT1 (p<0.05). SRT2183 reduced cell proliferation (p<0.05) but up-regulated the protein expressions of SIRT1, Caspase-3 and Caspase-8 (p<0.05), while EX 527 had the opposite effects (p<0.05).

Conclusions: MiR-141 may promote proliferation and reduce Apoptosis of colon Cancer cells via targeting SIRT1.

Figures
Products